(Nasdaq:CBMX), a diversified biotechnology business, through the development
of proprietary technologies, products and services in the areas of drug development,
genetic analysis, molecular diagnostics, nanotechnology research, defense and
homeland security markets, today announced that it ranked number 156 on Deloitte's
2008 Technology Fast 500, a ranking of the 500 fastest growing technology, media,
telecommunications and life sciences companies in North America. Rankings are
based on percentage of fiscal year revenue growth over five years, from 2003-2007.
Overall, companies that ranked on the 2008 Technology Fast 500 had growth
rates ranging from 242 to 138,762 percent over five years, with an average growth
rate of 3,043 percent.
CombiMatrix's President and CEO, Dr. Amit Kumar, credits a tremendously talented
and passionate team with the company's revenue growth from 2003-2007. Dr. Kumar
said, "We are pleased to be recognized by Deloitte & Touche for our
growth. This recognition is a testament to the hard work, talent and perseverance
of our employees. Our company is committed to the delivery of sophisticated
genetic tests for ill patients. We are doing this now and hope to expand into
the future and with additional life-saving products."
In addition to ranking on Deloitte's Technology Fast 500, CombiMatrix ranked
12th on the Washington Technology Fast 50, which is a ranking of the 50 fastest
growing technology firms in Washington State.
"Deloitte's Technology Fast 500 recognizes companies who have achieved
extraordinary growth in North America's most innovative and competitive market
sectors," said Phil Asmundson, Deloitte LLP vice chairman and national
managing partner for Technology, Media and Telecommunications. "We congratulate
CombiMatrix on this significant accomplishment."